http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5beb2e9ad8509656305e7b62b73b133
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Chanock |
| name | Stephen J. Chanock Stephen J Chanock |
| given-name | Stephen J. Stephen J |
| organization-name | 30Division of Cancer Epidemiology and Genetics, NCI, NIH, Department of Health and Human Services, Bethesda, Maryland. Authors' Affiliations: 1Henan Province Cancer Hospital, Office for Cancer Control and Prevention, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China; 2Yale University School of Public Health, New Haven, Connecticut; 3Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Rockville, Maryland; 4Wise Laboratory of Environmental and Genetic Toxicology, University of Southern Maine, Portland, Maine; 5Lanzhou University School of Public Health, Lanzhou, China; 6International Preventive Research Institute, Lyon, France; and 7Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS, Gaithersburg, Maryland.; Authors' Affiliations: 1Henan Province Cancer Hospital, Office for Cancer Control and Prevention, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China; 2Yale University School of Public Health, New Haven, Connecticut; 3Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Rockville, Maryland; 4Wise Laboratory of Environmental and Genetic Toxicology, University of Southern Maine, Portland, Maine; 5Lanzhou University School of Public Health, Lanzhou, China; 6International Preventive Research Institute, Lyon, France; and 7Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS, Gaithersburg, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda; 2Core Genotyping Facility, National Cancer Institute, SAIC-Frederick, Inc., Gaithersburg, Maryland; 3Division of Cancer Etiology, Department of Population Sciences, City of Hope and the Beckman Research Institute, Duarte, California; 4Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, Ohio; 5Division of Preventive Medicine; 6Division of Aging, Brigham and Women's Hospital, Harvard Medical School; 7Massachusetts Veterans Epidemiology, Research and Information Center, Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts; 8Fred Hutchinson Cancer Research Center; 9Department of Epidemiology, University of Washington, Seattle, Washington; 10Vanderbilt University Medical Center, Nashville, Tennessee; 11Department of Radiation Sciences, Oncology, Umeå University, Umeå; and 12Institute of Environmental Me; Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda; 2Core Genotyping Facility, National Cancer Institute, SAIC-Frederick, Inc., Gaithersburg, Maryland; 3Division of Cancer Etiology, Department of Population Sciences, City of Hope and the Beckman Research Institute, Duarte, California; 4Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, Ohio; 5Division of Preventive Medicine; 6Division of Aging, Brigham and Women's Hospital, Harvard Medical School; 7Massachusetts Veterans Epidemiology, Research and Information Center, Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts; 8Fred Hutchinson Cancer Research Center; 9Department of Epidemiology, University of Washington, Seattle, Washington; 10Vanderbilt University Medical Center, Nashville, Tennessee; 11Department of Radiation Sciences, Oncology, Umeå University, Umeå; and 12Institute of Environmental Me 6Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. 2National Cancer Institute Core Genotyping Facility, NIH, Department of Health and Human Services, Gaithersburg, Maryland; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; From the Molecular Genetics Section (M.M., A.B., A.S.) and the Laboratory of Neurogenetics (H.D., F.W.D.V., A.S.), National Institute on Aging, National Institutes of Health, Bethesda, Md; the Department of Biostatistical Sciences (W.M.B., L.D.C.), Division of Public Health Sciences, Wake Forest University Medical Center, Winston-Salem, NC; the Department of Neurology (T.G.B., D.G., J.F.M.), Mayo Clinic, Jacksonville, Fla; the Department of Neurology (R.D.B.), Mayo Clinic, Rochester, Minn; the... 1Division of Cancer Epidemiology and Genetics and; 2Pediatric Oncology Branch, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; Division of Cancer Epidemiology and Genetics National Cancer Institute Pike Bethesda MD; Core Genotyping Facility, Frederick National Laboratory for Cancer Research Gaithersburg MD Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, MD, USA Authors' Affiliations: 1Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Departments of 2Nutrition, and 3Biostatistics, Harvard School of Public Health; 4Department of Medicine, and 5Channing Division of Network Medicine, Brigham and Women's Hospital; 6Division of Gastroenterology, Massachusetts General Hospital; 7Department of Medicine, Harvard Medical School; 8Gastrointestinal Malignancy Program, and 9Medical-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; 10Public Health Sciences Division, Fred Hutchinson Cancer Research Center; 11Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington; 12Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; Divisions of 13Cancer Epidemiology and Genetics, and 14Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda; 15University of Maryland, School of Medicine, Baltimore, Maryland; 16Service de G Division of Cancer Epidemiology and Genetics National Cancer Institute, NIH Bethesda MD Division of Cancer Epidemiology and Genetics, National Cancer Institute National Institues of Health Bethesda Maryland USA Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20892, USA National Cancer Institute, Bethesda, MD; 5Core Genotyping Facility and; 6Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, Maryland; From the Immunocompromised Host Section, Pediatric Oncology Branch; Biostatistics and Data Management Section; HIV and AIDS Malignancy Branch; and Dermatology Branch, National Cancer Institute; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases; and Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD. Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 2Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 3Department of Family Medicine and Public Health Sciences and Barbara Ann Karmanos Institute, Wayne State University School of Medicine, Detroit, Michigan; and 4Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada Immunocompromised Host Section, Pediatric Oncology Branch,2 and; Advanced Technology Center,3 National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852;; Core Genotyping Facility, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Gaithersburg, MD 20877 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. 7Core Genotyping Facility, Advanced Technology Corp., National Cancer Institute, Gaithersburg, Maryland 20Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland. Department of Health and Human Services, Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health Bethesda Maryland From the Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute (NCI), National Institutes of Health (NIH); Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH; HIV and AIDS Malignancy Branch, NCI, NIH; Biostatistics and Data Management, NCI, NIH; Critical Care Medicine Department, Clinical Center, NIH; and the Dermatology Branch, NCI, NIH, Bethesda, MD. Division of Cancer Epidemiology and Genetics National Cancer Institute; NIH Bethesda MD USA 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; From the Section on Genomic Variation, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Gaithersburg, MD; the Molecular and Clinical Hematology Branch, NIDDK, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD; and MRC Laboratories, University of the West Indies, Kingston, Jamaica. 7Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas 5Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. 11Core Genotyping Facility, National Cancer Institute, Gaithersburg, Maryland; Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville Maryland United States of America 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; Authors' Affiliations: 1Division of Cancer Control and Population Sciences, 2Division of Cancer Epidemiology and Genetics, and 3Division of Cancer Prevention, National Cancer Institute, and 4Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland; 5Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia; 6Stanford Prevention Research Center, Department of Medicine, Department of Health Research and Policy, Stanford University School of Medicine, and Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, California; 7Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas; 8Division of Medicine, Brigham and Women's Hospital; 9Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; 10Department of Epidemiology and Nutrition, Harvard School of Public Health; 11Slone Epidemiology Center, Boston University, Boston, Massachusetts; 12Center for Healt 16Division of Cancer Epidemiology and Genetics, National Cancer Institute, U.S. NIH, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD, USA 4Department of Health and Human Services, Core Genotype Facility, National Cancer Institute, NIH, Gaithersburg, Maryland; 17Core Genotyping Facility, National Cancer Institute, Gaithersburg, Maryland; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health US Department of Health and Human Services Bethesda Maryland USA 7Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, Department of Health and Human Services National Cancer Institute, National Institutes of Health Rockville Maryland; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS Gaithersburg Maryland From the Immunocompromised Host Section, Pediatric Oncology Branch, the Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, and the Laboratory of Genetics, National Cancer Institute, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD. Division of Cancer Epidemiology and Genetics , Department of Health and Human Services, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892, United States 8Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. 1Genomics and Bioinformatics Group, Laboratory of Molecular Pharmacology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 2Core Genotyping Facility, NCI/Division of Cancer Epidemiology and Genetics, Advanced Technology Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, 3Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland, and 4Department of Bioinformatics and Computational Biology, M. D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Program in Molecular and Genetic Epidemiology, Departments of 2Epidemiology, 3Nutrition, and 4Biostatistics, Harvard School of Public Health; 5Division of Aging, Department of Medicine, Brigham and Women's Hospital; 6Department of Medicine, Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School; 7Massachusetts Veterans Epidemiology and Research Information Center (MAVERIC) and Geriatric Research, Education, and Clinical Center (GRECC), Boston Veterans Affairs Healthcare System, Boston, Massachusetts; 8Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 9Cancer Research Center of Lyon, Centre Léon Bérard, INSERM U1052; 10International Agency for Research on Cancer, Lyon, France; 11Departments of Medicine and Epidemiology and Biostatistics, School of Public Health, Imperial College, London; 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Ki Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda; 2Information Management Services, Inc., Rockville, Maryland; Departments of 3Genetics and 4Epidemiology, MD Anderson Cancer Center, University of Texas, Houston; 5Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas; 6American Cancer Society, Epidemiology and Surveillance Research, Atlanta, Georgia; 7Division of Epidemiology and Genetics, Institute of Cancer Research, Surrey; 8Cambridge Biomedical Centre, Cambridge, United Kingdom; and 9Unit of Epidemiology, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico and Department of Occupational and Environmental Health, University of Milan, Milan, Italy Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD; Advanced Technology Center, National Cancer Institute, Gaithersburg, MD 20892-4605, USA, Department of Biological Sciences, University of South Carolina, Columbia, SC 29208; Science Applications International Corporation (SAIC)-Frederick, National Cancer Institute, Frederick, MD 21702; and Core Genotyping Facility, Division of Cancer Epidemiology and Genetics, and Section on Genomic Variation, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda MD 20892-4605 3Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. Division of Cancer Epidemiology and Genetics; National Cancer Institute; Rockville Maryland 22Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Authors' Affiliations: 1Yale University School of Public Health; 2Yale University School of Medicine, New Haven, Connecticut; 3Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland; 4The Second Hospital of Lanzhou University; 5Gansu Provincial Tumor Hospital, Gansu Provincial Academy of Medical Sciences, Lanzhou, China; 6International Preventive Research Institute, Lyon, France; and 7Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS, Gaithersburg, Maryland; Authors' Affiliations: 1Yale University School of Public Health; 2Yale University School of Medicine, New Haven, Connecticut; 3Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland; 4The Second Hospital of Lanzhou University; 5Gansu Provincial Tumor Hospital, Gansu Provincial Academy of Medical Sciences, Lanzhou, China; 6International Preventive Research Institute, Lyon, France; and 7Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS, Gaithersburg, Maryland Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville MD 20850 The authors’ affiliations are as follows: the Centre for Cancer Genetic Epidemiology, Departments of Public Health and Primary Care (L.D., S. Carvalho, J.A., K.A.P., Q.W., M.K.B., J.D., B.D., N. Mavaddat, K. Michailidou, A.C.A., P.D.P.P., D.F.E.) and Oncology (C.L., P.A.H., C. Baynes, D.M.C., L.F., V.R., M. Shah, P.D.P.P., A.M.D., D.F.E.), University of Cambridge, Cambridge, the Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine (A. Campbell, D.J.P.), and the... Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Division of Cancer Epidemiology and Genetics (D.Alb., S.I.B., S.J.C., R.B.H., S.J.W.), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Authors' Affiliations: 1Cancer Epidemiology Program, Division of Population Sciences, Departments of 2Interdisciplinary Oncology, 3Biostatistics, 4Biomedical Informatics, 5Women's Oncology, and 6Health Outcomes and Behavior, Moffitt Cancer Center; 7Department of Epidemiology and Biostatistics, College of Public Health, and 8Pediatrics Epidemiology Center, College of Medicine, University of South Florida, Tampa, Florida; 9Case Comprehensive Cancer Center, Case School of Medicine, Cleveland, Ohio; 10Massachusetts General Hospital; 11Obstetrics and Gynecology Epidemiology Center, Brigham Women's Hospital, Boston, Massachusetts; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland; Departments of 13Laboratory Medicine and Pathology and 14Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota; 15Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre; 16Department of Gynaecologi Core Genotyping Facility, Advanced Technology Center, NCI, NIH, Gaithersburg, MD Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD Authors' Affiliations: 1Program in Molecular and Genetic Epidemiology; Departments of 2Epidemiology, and 3Nutrition, Harvard School of Public Health, Boston, Massachusetts; 4Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 5Genomic Epidemiology Group, 6Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 7Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom; 8Cancer Epidemiology and Genetics, and 9Cancer Prevention, National Cancer Institute, Bethesda, Maryland; 10Department of Epidemiology, Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke, Germany; 11National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Divisions of 12Preventive Medicine and 13Aging, Department of Medicine, Brigham and Women's Hospital, and 14Harvard Medical School, Boston, Massachusetts; 15Department of Ambulatory Care and Prevention, 16Division for Research and Educati Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD Division of Cancer Epidemiology and Genetics National Cancer Institute, Rockville Maryland United States of America Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute , Rockville, MD 20850, USA Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 2Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; 3Epidemiology Research Program, American Cancer Society, Atlanta, Georgia; 4Spanish National Cancer Research Centre; 5Ramón y Cajal University Hospital, Madrid, Spain; 6Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; 7Department of Epidemiology, Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 8Centre for Research in Environmental Epidemiology (CREAL); 9CIBER Epidemiología y Salud Pública (CIBERESP); 10Universitat Pompeu Fabra; 11Hospital del Mar-Institut Municipal d'Investigació Mèdica (IMIM), Universitat Pompeu Fabra, Barcelona, Spain; 12National School of Public Health, Athens, Greece; 13Core Genotype Facility, SAIC-Frederick, Inc., National Cancer Institute-Frederick, Frederick, Maryland; 14Universidad de Oviedo, Ovie 5Core Genotype Facility, National Cancer Institute, NIH, Department of Health and Human Services, Gaithersburg, Maryland; and 53Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Core Genotyping Facility Frederick National Laboratory for Cancer Research, Gaithersburg, MD, USA. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD Authors' Affiliations: 1Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; 2Host Susceptibility Factors Branch, Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, Rockville, Maryland; 3Howard Hughes Medical Institute, Chevy Chase, Maryland; 4Gradient Corporation, Cambridge, Massachusetts; and 5Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, Maryland Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland and 2Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 1Section of Genomic Variation, Pediatric Oncology Branch and; 5Core Genotyping Facility, Division of Cancer Epidemiology and Genetics; and From the Vascular Biology (P.J.P., J.K.C.) and Myocardial Biology (D.A.S., W.S.C.) Laboratories, Boston Medical Center, Boston, Mass; and the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (S.J.C.). 1Division of Cancer Epidemiology and Genetics,; 4Pediatric Oncology Branch, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD; Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, MD 20850 , United States NATIONAL CANCER INSTITUTE Division of Cancer Epidemiology and Genetics, National Cancer Institute, Advanced Technology Center, Gaithersburg, Maryland. 6Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 3Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. Authors' Affiliations: 1Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics and 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; 3Core Genotyping Facility, Advanced Technology Program, Science Applications International Corporation-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 4Bioinformed Consulting Services, Gaithersburg, Maryland; 5Department of Environmental Medicine, NYU School of Medicine, New York, New York; 6Program in Molecular and Genetic Epidemiology, Department of Epidemiology and 7Department of Nutrition, Harvard School of Public Health; 8Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; 9Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 10Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; 11Centre de Recherche pour les Patholog; Authors' Affiliations: 1Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics and 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; 3Core Genotyping Facility, Advanced Technology Program, Science Applications International Corporation-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 4Bioinformed Consulting Services, Gaithersburg, Maryland; 5Department of Environmental Medicine, NYU School of Medicine, New York, New York; 6Program in Molecular and Genetic Epidemiology, Department of Epidemiology and 7Department of Nutrition, Harvard School of Public Health; 8Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; 9Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 10Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; 11Centre de Recherche pour les Patholog; Authors' Affiliations: 1Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics and 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; 3Core Genotyping Facility, Advanced Technology Program, Science Applications International Corporation-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 4Bioinformed Consulting Services, Gaithersburg, Maryland; 5Department of Environmental Medicine, NYU School of Medicine, New York, New York; 6Program in Molecular and Genetic Epidemiology, Department of Epidemiology and 7Department of Nutrition, Harvard School of Public Health; 8Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; 9Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 10Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; 11Centre de Recherche pour les Patholog Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute National Institutes of Health Bethesda Maryland Division of Cancer Epidemiology and Genetics, National Cancer Institute Bethesda MD From the Baylor College of Medicine (C.D.C.), Division of Cardiovascular Anesthesiology at the Texas Heart Institute, St. Luke’s Episcopal Hospital, Houston, Texas; the Department of Anesthesiology, Perioperative and Pain Medicine (S.K.S., A.A.F., S.C.B.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; the Center for Cancer Research (T.B., S.J.C.), National Cancer Institute, Bethesda, Md; the Division of Biostatistics and Epidemiology (W.K.V.), Texas Heart Institute, St Luke’s... Office of the Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. National Institutes of Health, Bethesda, Maryland 4National Cancer Institute Core Genotyping Facility, NIH, Department of Health and Human Services, Gaithersburg, Maryland; and Core Genotyping Facility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4605; Section on Genomic Variation, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Gaithersburg, Maryland 20892-4605 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD Core Genotyping Facility NCI‐Frederick, SAIC‐Frederick Inc, and Division of Cancer Epidemiology and Genetics Bethesda MD, USA 4NCI, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD; National Cancer Institute, Bethesda, USA. 3Core Genotyping Facility,; 4Division of Cancer Epidemiology and Genetics, and; 5Section on Genomic Variation, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Rockville, MD;; Core Genotyping Facility, Advanced Technology Center, NCI, NIH, DHHS, Gaithersburg, MD; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, and Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics and 2Neuro-oncology Branch, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; 3Division of Cancer Etiology, Department of Population Sciences, City of Hope National Medical Center and The Beckman Research Institute, Duarte, California; and 4Core Genotyping Facility, Advanced Technology Program, SAIC Frederick, Inc., National Cancer Institute-Frederick, Frederick, Maryland 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland;; 7Core Genotyping Facility, Advanced Technology Corporation, National Cancer Institute, Gaithersburg, Maryland Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA 9Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS, Gaithersburg, Maryland; and Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville Maryland; Core Genotyping Facility National Cancer Institute, SAIC‐Frederick, Inc Gaithersburg Maryland Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health Bethesda MD Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA; Core Genotyping Facility, National Cancer Institute, SAIC-Frederick, Inc, Gaithersburg, Maryland, USA Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA; Authors' Affiliations: 1Center for Cancer Epidemiology and Prevention; Departments of 2Health Studies, 3Medicine, and 4Human Genetics; 5Comprehensive Cancer Center, University of Chicago, Chicago, Illinois; 6Department of Health Research and Policy, Stanford University School of Medicine; 7Stanford Cancer Institute, Stanford; 8Cancer Prevention Institute of California, Fremont; 9Department of Preventive Medicine, University of Southern California, Los Angeles; 10Stanford Cancer Institute, Palo Alto, California; 11Epidemiology and Genetics Research Program; 12Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 13Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 14Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 15Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York; 16Integrated Cancer Genomics Division, Tr 1Division of Cancer Epidemiology and Genetics and; 2Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland; 1Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. Authors' Affiliations: 1Public Health Sciences Division, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington; 3Department of Biostatistics, University of Washington, Seattle; Divisions of 4Cancer Epidemiology, 5Clinical Epidemiology and Aging Research, and 6Preventive Oncology, German Cancer Research Center, Heidelberg, Germany; 7Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City; 8Translational Genomics Research Institute, Phoenix; 9Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School; 10Program in Molecular and Genetic Epidemiology, Department of Epidemiology, and 11Departments of Epidemiology and Nutrition, Harvard School of Public Health; 12Department of Medical Oncology, Dana-Farber Cancer Institute; 13Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston; 14,15Ontario Institute for Cancer Research; 16Department of Surgery, Universit 1Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Authors' Affiliations: 1Program in Molecular and Genetic Epidemiology, Department of 2Epidemiology, 3Nutrition, and 4Biostatistics, Harvard School of Public Health, 5Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 7Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden; 8Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 9Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; and 10Division of Epidemiology, NYU Langone Medical Center, New York, New York Authors' Affiliations: Departments of 1Oncology and 2Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge; 3Eastern Cancer Registration and Information Centre, Unit C-Magog Court, Cambridge, United Kingdom; 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland; and 5Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Gaithersburg, MD National Cancer Institute, National Institutes of Health, Bethesda, MD 1Pediatric Oncology Branch and 2Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.; 7Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, Maryland. 1Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland. Authors' Affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, Maryland Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA 92 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland 100Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; 10Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, MD Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, 2Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, NIH, Bethesda, Maryland; 3Academy of Mathematics and Systems Science, Chinese Academy of Science, Beijing, China; and 4German National Cancer Center, Division of Cancer Epidemiology, Heidelberg, Germany 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA Pediatric Oncology Branch, Division of Clinical Sciences, National Cancer Institute (S.J.C.), Bethesda, Maryland 20892 Division of Cancer Epidemiology and Genetics, and Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom 11Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland. 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. From the National Cancer Institute, Rockville, MD. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA Authors' Affiliations: 1Department of Medical Oncology, Dana-Farber Cancer Institute; 2Channing Laboratory and 3Divisions of Preventive Medicine and Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Departments of 4Epidemiology, 5Biostatistics, and 6Nutrition, Harvard School of Public Health; 7Department of Ambulatory Care and Prevention, Harvard Medical School; 8Physicians' Health Study, Divisions of Aging, Cardiovascular Medicine, and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and Massachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts; 9Department of Laboratory Medicine/Pathology, School of Medicine, University of Minnesota, Minneapolis, Minnesota; 10Prevention and Research Center, Mercy Medical Center, Baltimore, Maryland; 11National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, and Department o; Authors' Affiliations: 1Department of Medical Oncology, Dana-Farber Cancer Institute; 2Channing Laboratory and 3Divisions of Preventive Medicine and Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Departments of 4Epidemiology, 5Biostatistics, and 6Nutrition, Harvard School of Public Health; 7Department of Ambulatory Care and Prevention, Harvard Medical School; 8Physicians' Health Study, Divisions of Aging, Cardiovascular Medicine, and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and Massachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts; 9Department of Laboratory Medicine/Pathology, School of Medicine, University of Minnesota, Minneapolis, Minnesota; 10Prevention and Research Center, Mercy Medical Center, Baltimore, Maryland; 11National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, and Department o 10Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, Maryland 9Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, Department of Health and Human Services National Cancer Institute, National Institutes of Health Bethesda Maryland USA Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; Division of Cancer Epidemiology and Genetics; National Cancer Institute; Bethesda; MD; USA 1Pediatric Oncology Branch, Center for Cancer Research and Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA, Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892–4605, USA. 3Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health, Department of Health and Human Services Bethesda MD Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850, USA From the Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; Terry Fox Laboratory, BC Cancer Research Center, Vancouver; Department of Medicine, University of British Columbia, Vancouver, Canada; and the Section on Genomic Variation, Pediatric Oncology Branch, National Cancer Institutes, Advanced Technology Center, Gaithersburg, MD Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Division of Cancer Genetics and Epidemiology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute National Institutes of Health Bethesda Maryland USA 3Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD Authors' Affiliations: 1Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute and City of Hope, Duarte, California; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, Maryland; 3Division of Epidemiology, College of Medicine, Mayo Clinic, Rochester, Minnesota; 4Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California; 5Department of Family Medicine and Karmanos Cancer Institute, Wayne State University, Detroit, Michigan; 6Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington; and 7Core Genotyping Facility, SAIC-Frederick, Inc., National Cancer Institute, NIH, DHHS, Gaithersburg, Maryland; Authors' Affiliations: 1Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute and City of Hope, Duarte, California; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, Maryland; 3Division of Epidemiology, College of Medicine, Mayo Clinic, Rochester, Minnesota; 4Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California; 5Department of Family Medicine and Karmanos Cancer Institute, Wayne State University, Detroit, Michigan; 6Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington; and 7Core Genotyping Facility, SAIC-Frederick, Inc., National Cancer Institute, NIH, DHHS, Gaithersburg, Maryland 8Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, U.S. Department of Health and Human Services, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics National Cancer Institute (NCI) National Institutes of Health (NIH) Bethesda Maryland 20892 USA Division of Cancer Epidemiology and Genetics , National Cancer Institute, National Institutes of Health, Bethesda, MD 20850 , USA National Cancer Institute, Bethesda, MD, USA 4Advanced Technology Center, National Cancer Institute, NIH, Department of Health and Human Services, Gaithersburg, Maryland; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Department of Health and Human Services, Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health Bethesda Maryland USA Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland,1 and Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD; Core Genotyping Facility Frederick National Laboratory for Cancer Research Gaithersburg MD 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, MD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Washington, DC. 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland and Authors' Affiliations: 1Department of Urology, Northwestern University Feinberg School of Medicine; and 2Department of Medicine, University of Illinois, Chicago, Illinois; 3Division of Genetic Epidemiology, University of Utah, Salt Lake City, Utah; 4National Human Genome Research Institute, NIH; and 5Department of Urology and Oncology, Johns Hopkins Medical Institutions, Baltimore, 6Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, and Core Genotyping Facility, SAIC-Frederick, Inc., National Cancer Institute, NIH, DHHS, Gaithersburg; and 7Genome Technology Branch, National Human Genome Research Institute, NIH; and 8Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland; 9Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; 10Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; and 11The Institute of Cancer Research, Surrey, and T 4National Cancer Institute, Bethesda, Maryland; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Bethesda, MD, USA Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA 1Division of Cancer Epidemiology and Genetics and; 11Core Genotyping Facility, Advanced Technology Program, Science Applications International Corporation-Frederick, Inc., National Cancer Institute-Frederick, Frederick, Maryland Division of Cancer Epidemiology and Genetics, National Cancer Institute National Institutes of Health Rockville Maryland USA 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. Division of Cancer Epidemiology & Genetics National Cancer Institute, NIH, DHHS Bethesda Maryland USA Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD Departments of Immunology and Cell Biology, The Scripps Research Institute, La Jolla, California 92037, and Immunocompromised Host Section, Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, 20892,USA Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD;; 2Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, Gaithersburg, Maryland;; 4Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 4Core Genotyping Facility, Advanced Technology Program, SAIC Frederick, Inc, NCI-Frederick, Frederick, Maryland Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 10Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. Authors' Affiliations:1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; 2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 3Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 4Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 5Information Management Services, Silver Spring, Maryland; 6Division of Hematology & Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden; 7Department of Obstetrics and Gynecology, New York University School of Medicine, New York; 8Department of Environmental Medicine, New York University School of Medicine, New York; 9New York University Cancer Institute, New York; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands; 12Departme; Authors' Affiliations:1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; 2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 3Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 4Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 5Information Management Services, Silver Spring, Maryland; 6Division of Hematology & Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden; 7Department of Obstetrics and Gynecology, New York University School of Medicine, New York; 8Department of Environmental Medicine, New York University School of Medicine, New York; 9New York University Cancer Institute, New York; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands; 12Departme Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20890, USA. Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; Departments of 2Epidemiology and 3Nutrition, Harvard School of Public Health; Divisions of 4Preventive Medicine, 5Aging, and 6Cardiovascular Disease, 7Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 8VA Boston Healthcare System, Boston, Massachusetts; 9Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 10Epidemiology Research Program, American Cancer Society, Atlanta, Georgia; 11Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; 12Department of Biology, University of Pisa, Pisa; 13Cancer Research and Prevention Institute—ISPO, Florence, Italy; 14Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 15National Institute for Public Hea Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; From the Department of Immunology, Genentech Inc, South San Francisco, CA; The Scripps Research Institute, Department of Molecular and Experimental Medicine, La Jolla, CA; the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; and the University of Antioquia School of Medicine, Medellin, Colombia, South America. 16Core Genotyping Facility, Science Applications International Corporation-Frederick, Inc., National Cancer Institute at Frederick, Gaithersburg, Maryland; 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Rockville, Maryland;; 3Core Genotyping Facility, Advanced Technology Center, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland;; 10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland Authors' Affiliations: 1Program in Molecular and Genetic Epidemiology, Departments of 2Epidemiology, 3Nutrition, and 4Biostatistics, Harvard School of Public Health; 5Massachusetts Veterans Epidemiology and Research Information Center (MAVERIC) and Geriatric Research, Education, and Clinical Center (GRECC), Boston Veterans Affairs Healthcare System; 6Division of Aging, Department of Medicine, 7Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 8Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 9Genomic Epidemiology Group, German Cancer Research Center DKFZ, Heidelberg, Germany; 10Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 11Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri; 12National Institute for Public Health and the Environment (RIVM), Bilthoven; 13Department of Gastro |
Incoming Links
Total number of triples: 1025.